PAN-01-102 - Multicenter Phase I/II Study to Evaluate Safety and Tolerability of Pan-90806 Eye Drops Suspension in Treatment-Naive Participants with Neovascular Age-Related Macular Degeneration (AMD)

Administered By

Awarded By

Contributors

Start/End

  • April 4, 2018 - April 2, 2020